在接受减肥手术的致病性肥胖患者中,与输出管相关的并发症的危险因素:一项回顾性队列研究
Ayten Saracoglu1,2, Atchyuta R R Vegesna1, Bushra M Abdallah3
1Department of Anesthesiology, ICU and Perioperative Medicine, Hamad Medical Corporation, Doha, Qatar.
Journal of anesthesia
|March 29, 2025
概括
气管输出并发症,特别是脱,在接受腹手术的致病肥胖患者中很常见. 增加的肥胖和诸如高血压之类的并发病增加了这些风险,需要量身定制的监测和策略.
科学领域:
- 麻醉学 麻醉学
- 腹部外科 腹部外科
- 关键护理医学 关键护理医学
背景情况:
- 与麻醉相关的呼吸道并发症经常在气管输出过程中发生.
- 致病性肥胖症显著影响呼吸功能,增加了手术风险.
- 腹部外科手术患者的输管并发症以前没有研究过.
研究的目的:
- 为了确定腹腔外科手术患者中气管除并发症的速度和频率.
- 为了确定与这些输出管相关并发症相关的风险因素.
主要方法:
- 对1193名接受减肥手术的成年患者 (BMI ≥40 kg/m2) 的回顾性队列研究.
- 并发症包括吐,吸血,喉发作,支气管发作,心血管不稳定,呼吸道,脱,或需要救援装置/再输管.
- 逻辑回归分析,根据年龄和性别进行调整,以本费罗尼对显著性进行校正 (p < 0.0031).
主要成果:
- 整体并发症率为4.4%,其中脱是最常见的 (3.2%).
- 增加的肥胖 (BMI 50-59 kg/m2和>60 kg/m2) 和并发症 (高血压,阻塞性睡眠呼吸暂停) 显示出更高并发症几率的趋势.
- 经过邦费罗尼校正后,没有任何关联仍然具有统计学意义.
结论:
- 脱是患有病态肥胖症的减肥手术患者中最常见的输出管后并发症.
- 较高的肥胖类和诸如高血压和OSA之类的并发症与输出管相关的并发症风险增加有关.
- 量身定制的输出策略和密切的术后监测对于减轻这一群体的风险至关重要.
相关概念视频
Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Endotracheal Intubation II: Nursing Management
Endotracheal intubation is a critical procedure that can be lifesaving for many patients with respiratory distress or failure. The role of nursing in managing endotracheal tubes is pivotal, as it involves pre-intubation preparation, assisting during the procedure, and post-extubation care.
1. Nursing Care of Patients Before Intubation
Before the endotracheal intubation procedure, nurses play an essential role in ensuring the process goes smoothly. The nurses must be familiar with intubation...
1. Nursing Care of Patients Before Intubation
Before the endotracheal intubation procedure, nurses play an essential role in ensuring the process goes smoothly. The nurses must be familiar with intubation...
Endotracheal Tube Extubation
Endotracheal tube extubation is a critical procedure in weaning patients from mechanical ventilation. It involves physically removing the oral or nasal endotracheal (ET) tube, marking the final step in liberating a patient from ventilatory support.
Procedure
Extubation removes the endotracheal tube (ETT) from the patient on mechanical ventilation. It requires a well-coordinated, multidisciplinary approach involving physicians, nurses, respiratory therapists, and other healthcare professionals.
Procedure
Extubation removes the endotracheal tube (ETT) from the patient on mechanical ventilation. It requires a well-coordinated, multidisciplinary approach involving physicians, nurses, respiratory therapists, and other healthcare professionals.
Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...


